Are receptors for a small neuropeptide associated with neural signaling. They can play a key role in the diagnosis and treatment of neuroendocrine tumors (NETs).

A Somatostatin Receptor Protein on a tumor cell which can act as a target for certain Neuroendocrine Cancer drugs. See also: Receptor Positive

A marker protein for neuroendocrine tumors.

An emerging radiopharmaceutical therapy utilizing alpha particle emitters. The short range emission of alpha particle energy is expected to provide greater localized efficacy killing cancer cells while reducing toxic effects to surrounding heathy tissue. See Also: Alpha Particles

Line of treatments which combine one radioactive drug to diagnose and a second radioactive drug delivered to primary and metastasis tumors for treatment.

Brand name for a prescription drug used to inhibit carcinoid syndrome diarrhea not satisfactorily controlled by SSAs. Also prescribed to control the overproduction of serotonin.

A radioactive substance or tracer that is used in a PET scan to detect the location of NETs. Also called flurodopa or 18F-DOPA.

The destruction or removal of a body part, like a part of an organ, a growth, or some internal structure. Ablation can be done with surgery, heat, radio waves, hormones, or drugs.

A gland near the top of the kidney that creates hormones, like adrenaline and cortisol. Your body has 2 adrenal glands.

A hormone and neurotransmitter. Also called epinephrine.

Another name for side effects.

A hormone also known as corticotrophin. It is produced by the anterior pituitary gland.

Cells that help regulate various body functions, such as growth, reproduction and metabolism. There are three types of endocrine cells; alpha cells which secrete glucagon, beta cells which secrete insulin, and delta cells which suppress the secretion of glucagon and insulin.

Medical speciality that investigates the factors which determine the presence or absence of a disease, plus it’s incidence and it’s prevalence.

Oral chemotherapy indicated for the treatment of adult patients with advanced or high grade Neuroendocrine Tumors.

A term used to describe the speed or extent to which a tumor grows and spreads.

A type of diagnostic imaging that uses X-rays enhanced with a radiographic contrast medium.

Term sometimes used for a kind of neuroendocrine tumor (NET) in the lungs. A lung NET described as an atypical carcinoid tends to be faster growing than a typical carcinoid, but is not as aggressive as a high-grade lung NET.

A noncancerous growth that does not invade nearby tissue or spread from one part of the body to another.

A substance that can be found in the blood or in the body that is associated with the presence of disease. In cancers, specific biomarkers can point to the presence of specific cancers. With names like CA 125 (which can indicate ovarian cancer) and CEA (which can mean lung, ovarian, breast, pancreatic, or digestive tract tumors), biomarkers are also called tumor markers. Some biomarkers related to carcinoid tumors are CgA and Ki-67